Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Engineering strategies to enhance oncolytic viruses in cancer immunotherapy
Yaomei Tian, Daoyuan Xie, Yang Li
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 164

Showing 1-25 of 164 citing articles:

Evolving therapeutic landscape of advanced hepatocellular carcinoma
Chen Yang, Hailin Zhang, Linmeng Zhang, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 4, pp. 203-222
Closed Access | Times Cited: 429
Thermal immuno-nanomedicine in cancer
Zhe Yang, Di Gao, Jing Zhao, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 2, pp. 116-134
Closed Access | Times Cited: 143
Cancer treatments: Past, present, and future
Dmitriy Sonkin, Anish Thomas, Beverly A. Teicher
Cancer Genetics (2024) Vol. 286-287, pp. 18-24
Open Access | Times Cited: 98
An oncolytic virus–T cell chimera for cancer immunotherapy
Yuxuan Chen, Xiaohong Chen, Weier Bao, et al.
Nature Biotechnology (2024)
Closed Access | Times Cited: 27
ERK pathway agonism for cancer therapy: evidence, insights, and a target discovery framework
Oleg Timofeev, Philippe Giron, Steffen Lawo, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Oncolytic Virotherapy: A New Paradigm in Cancer Immunotherapy
Simona Ruxandra Volovăț, Dragoş Viorel Scripcariu, Ingrid-Andrada Vasilache, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1180-1180
Open Access | Times Cited: 20
Fn-OMV potentiates ZBP1-mediated PANoptosis triggered by oncolytic HSV-1 to fuel antitumor immunity
Shuo Wang, An Song, Jun Xie, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 20
Oncolytic vaccinia virus and cancer immunotherapy
Lihua Xu, Huihui Sun, Nicholas R. Lemoine, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 17
SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis
Fanghui Chen, Liwei Lang, Jianqiang Yang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Emerging Trends in Immunotherapy for Cancer
Alok Mishra, Amjad Ali, Shubham Dutta, et al.
Diseases (2022) Vol. 10, Iss. 3, pp. 60-60
Open Access | Times Cited: 46
Oxidative Stress Amplifiers as Immunogenic Cell Death Nanoinducers Disrupting Mitochondrial Redox Homeostasis for Cancer Immunotherapy
Jia Wan, Xianghong Zhang, Zhihong Li, et al.
Advanced Healthcare Materials (2022) Vol. 12, Iss. 9
Closed Access | Times Cited: 45
Drug repurposing for viral cancers: A paradigm of machine learning, deep learning, and virtual screening‐based approaches
Faheem Ahmed, In Suk Kang, Kyung Hwan Kim, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 39
Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
Lingjuan Chen, Mengsi Zuo, Qin Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 32
Inhibition of Tumor Metastasis by Liquid‐Nitrogen‐Shocked Tumor Cells with Oncolytic Viruses Infection
Qing Wu, Hanwei Huang, Mengchi Sun, et al.
Advanced Materials (2023) Vol. 35, Iss. 28
Closed Access | Times Cited: 29
Construction and application of adenoviral vectors
Hongbo Zhang, Hongdan Wang, Youcai An, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 34, pp. 102027-102027
Open Access | Times Cited: 28
Oncolytic virus-based combination therapy in breast cancer
Amirhossein Bahreyni, Yasir Mohamud, Honglin Luo
Cancer Letters (2024) Vol. 585, pp. 216634-216634
Open Access | Times Cited: 14
Therapeutic bacteria and viruses to combat cancer: double-edged sword in cancer therapy: new insights for future
Aref Yarahmadi, M. Amin Zare, Masoomeh Aghayari, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Enhancing cancer therapy: the integration of oncolytic virus therapy with diverse treatments
Yan Zhuo, Zhengbo Zhang, Yanan Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 11
Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis
Yuanyuan Wang, Jingting Wang, Shuo Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 31, pp. 20167-20180
Closed Access | Times Cited: 9
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Exploring enterovirus pathogenesis and cancer therapy potential through reverse genetics
Shijin Wang, Qinghua Yu, Zhou Junfeng, et al.
Biosafety and Health (2025)
Open Access | Times Cited: 1
Surgically Derived Cancer Cell Membrane-Coated R837-Loaded Poly(2-Oxazoline) Nanoparticles for Prostate Cancer Immunotherapy
Shengxian Li, Dong Si, Jing Wu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 6, pp. 7878-7886
Closed Access | Times Cited: 21
The Clinical Advances of Oncolytic Viruses in Cancer Immunotherapy
Mohammed Zolaly, Waleed H. Mahallawi, Zakaria Yahya Khawaji, et al.
Cureus (2023)
Open Access | Times Cited: 21
The Dilemma of HSV-1 Oncolytic Virus Delivery: The Method Choice and Hurdles
Guijin Tang, Dawei Wang, Xiangqian Zhao, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3681-3681
Open Access | Times Cited: 19
Development and application of oncolytic viruses as the nemesis of tumor cells
Xiao Zhu, Chenyang Fan, Zhuolong Xiong, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top